HomeCompareMITSY vs MRK

MITSY vs MRK: Dividend Comparison 2026

MITSY yields 1.82% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MITSY wins by $43.28M in total portfolio value· pulled ahead in Year 3
10 years
MITSY
MITSY
● Live price
1.82%
Share price
$761.75
Annual div
$13.89
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.34M
Annual income
$39,204,808.75
Full MITSY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MITSY vs MRK

📍 MITSY pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMITSYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MITSY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MITSY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MITSY
Annual income on $10K today (after 15% tax)
$154.99/yr
After 10yr DRIP, annual income (after tax)
$33,324,087.44/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MITSY beats the other by $33,315,759.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MITSY + MRK for your $10,000?

MITSY: 50%MRK: 50%
100% MRK50/50100% MITSY
Portfolio after 10yr
$21.70M
Annual income
$19,607,303.45/yr
Blended yield
90.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MITSY
No analyst data
Altman Z
2.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MITSY buys
0
MRK buys
0
No recent congressional trades found for MITSY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMITSYMRK
Forward yield1.82%2.76%
Annual dividend / share$13.89$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$43.34M$56.8K
Annual income after 10y$39,204,808.75$9,798.13
Total dividends collected$42.99M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MITSY vs MRK ($10,000, DRIP)

YearMITSY PortfolioMITSY Income/yrMRK PortfolioMRK Income/yrGap
1$11,065$364.69$11,206$366.19$141.00MRK
2$12,593$754.23$12,650$502.35$57.00MRK
3← crossover$15,080$1,604.56$14,407$694.19+$673.00MITSY
4$19,726$3,591.26$16,585$967.82+$3.1KMITSY
5$29,888$8,781.16$19,342$1,363.89+$10.5KMITSY
6$56,849$24,868.72$22,913$1,947.19+$33.9KMITSY
7$149,243$88,414.23$27,662$2,823.89+$121.6KMITSY
8$593,538$433,847.60$34,159$4,173.35+$559.4KMITSY
9$3,860,145$3,225,059.61$43,337$6,308.80+$3.82MMITSY
10$43,335,164$39,204,808.75$56,776$9,798.13+$43.28MMITSY

MITSY vs MRK: Complete Analysis 2026

MITSYStock

Mitsui & Co., Ltd. operates as a general trading company worldwide. The company engages in the manufacture, export, and import of iron and steel products; automotive components; operation of steel processing service centers; trading of automotive, electrical, special, and stainless steel; manufacture, repair, and fabrication of wind turbine towers and flanges; gas distribution businesses; and coal mining, power generation, ferrous alloy, infrastructure maintenance, and water pumping activities. It also explores, develops, and produces oil, natural gas, and LNG; trades in petroleum products, crude oil, coal, uranium, and LNG; offers FPSO/FSO, fright car, truck, and locomotive leasing services; sells electric power facilities; and develops railway and transportation infrastructures. The company engages in logistics businesses; wholesale, retail, rental, and finance of construction and mining equipment; multimodal transportation, warehousing, and rolling stock leasing; sale, purchase, and leasing of aircraft and aero engines; leasing and financing activities; and development, process, and marketing of underground resources, and recycling of surface resources. It also provides electric-arc-furnace, construction materials processing, construction flat-rolled steel, shapes, bars, wire rods, and steel structure materials; methanol, ammonia, chlor-alkali, industrial, gas, and basic chemicals; salt; performance, advanced, specialty, and living, and environmental materials; agrochemicals and fertilizers, and animal and human nutrition products; refined sugar, oils and fats, proteins, grains, and food and beverage products; contract food services; and healthcare products. The company offers mobile communications; commodity derivative trading; venture investment and asset management services; real estate development, management, leasing, and brokerage services; and ship charter operation services. Mitsui & Co., Ltd. was incorporated in 1947 and is headquartered in Tokyo, Japan.

Full MITSY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MITSY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MITSY vs SCHDMITSY vs JEPIMITSY vs OMITSY vs KOMITSY vs MAINMITSY vs JNJMITSY vs ABBVMITSY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.